Skip to main content

Table 2 Comparison of clinical data between patients with no/mild and advanced fibrosis

From: Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)

Variable normal values

Fibrosis 0-2 (n = 88)

Fibrosis 3-4 (n = 15)

p

Age (years)

45.0 ± 12.0

53.0 ± 9.0

P = 0.028

BMI (19-25 kg/m2)

29.5 ± 3.61

30.79 ± 4.90

P = 0.221

AST (<38 IU/L)

52.73 ± 33.36

69.20 ± 45.18

P = 0.097

ALT (<41IU/L)

91.60 ± 56.94

61.53 ± 37.25

P = 0.052

AST/ALT ratio

0.69 ± 0.56

1.32 ± 0.57

P < 0.001

Glucose (3.89-5.83 mmol/L)

5.5 ± 1.08

6.99 ± 1.98

P = 0.011

Insulin (41.7-187.5 pmol/L)

132 ± 184

249.3 ± 148.6

P = 0.037

PLT (150-400x109/L)

226.6 ± 61,9

192.3 ± 63.9

P = 0.051

Albumin (34-48 g/L)

43 ± 4.0

43 ± 4.0

P = 0.842

HBA1c (4.8-5.9%)

5.8 ± 1.0

7.5 ± 1.8

P = 0.108

HOMA (<1.8)

4.6 ± 6.2

12.2 ± 9.8

P = 0.030